Status: Recruiting
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres
Participants needed: 845
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Sirtex MedicalUpdated: Nov 27, 2024Locations: 9Duration: 2 Years
Eligibility criteria
Age 18 years or older [+5]
Prior radiation treatment to the liver [+2]